Bio Essence Corporation (BIOE)
OTCMKTS · Delayed Price · Currency is USD
0.0550
0.00 (0.00%)
Feb 9, 2026, 4:00 PM EST

Bio Essence Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
0.570.32-0.620.890.96
Revenue Growth (YoY)
----30.00%-7.38%16.02%
Cost of Revenue
0.170.11-0.290.590.73
Gross Profit
0.390.22-0.330.30.23
Selling, General & Admin
0.520.680.350.841.151.06
Operating Expenses
0.520.680.350.841.161.06
Operating Income
-0.13-0.46-0.35-0.51-0.86-0.83
Interest Expense
-0-0-0-0.01-0.04-0.04
Other Non Operating Income (Expenses)
-0.03-0.05-0.06-00.010.04
EBT Excluding Unusual Items
-0.16-0.51-0.4-0.53-0.89-0.84
Asset Writedown
--1.05----
Other Unusual Items
----0.240.24
Pretax Income
-0.16-1.56-0.4-0.53-0.64-0.59
Income Tax Expense
000000
Earnings From Continuing Operations
-0.16-1.57-0.4-0.53-0.65-0.6
Earnings From Discontinued Operations
-0.26-0.57-0.28--
Net Income
-0.16-1.31-0.97-0.81-0.65-0.6
Net Income to Common
-0.16-1.31-0.97-0.81-0.65-0.6
Shares Outstanding (Basic)
383834333333
Shares Outstanding (Diluted)
383834333333
Shares Change (YoY)
5.50%11.94%2.86%--0.08%0.58%
EPS (Basic)
-0.00-0.03-0.03-0.02-0.02-0.02
EPS (Diluted)
-0.00-0.03-0.03-0.02-0.02-0.02
Free Cash Flow
0.750.62-1.03-0.71-1.41-0.74
Free Cash Flow Per Share
0.020.02-0.03-0.02-0.04-0.02
Gross Margin
69.28%67.01%-52.82%33.60%23.71%
Operating Margin
-22.23%-141.83%--82.23%-96.57%-86.84%
Profit Margin
-28.37%-404.02%--130.26%-72.92%-62.15%
Free Cash Flow Margin
132.90%192.59%--113.74%-159.19%-77.20%
EBITDA
-0.13-0.46-0.34-0.5-0.82-0.8
EBITDA Margin
-22.15%-141.47%--79.90%-92.54%-83.37%
D&A For EBITDA
0000.010.040.03
EBIT
-0.13-0.46-0.35-0.51-0.86-0.83
EBIT Margin
-22.23%-141.83%--82.23%-96.57%-86.84%
Revenue as Reported
0.570.32-0.620.890.96
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.